CMV continues to be associated with post transplantation morbidity and mortality. Drugs used for prophylaxis and treatment of CMV infection can cause pancytopenia and impair renal function, adding ...

every 12 hSevere CMV disease, GI disease, pneumonia, CNS disease: Ganciclovir 5 mg/kg iv. every 12 hGanciclovir-resistant CMV disease: Foscarnet 60 mg/kg iv. every 8 h or 90 mg/kg iv. every 12 h ...

The Los Angeles County Department of Public Health has declared a community-wide outbreak of hepatitis A following a sustained increase in clinical cases and elevated virus levels detected in local ...

Neurological disorders caused by Cytomegalovirus (CMV) in patients with Acquired Immunodeficiency Syndrome (AIDS) are rarely reported in the Highly Active Antiretroviral Therapy (HAART) period. The ...

Few compounds such as maribavir, CMX-001 and AIC-246 are being developed for CMV prevention and treatment. There is also an increasing number of drugs for treating chronic viral hepatitis B and C.

At least seven people have died. By Emily Baumgaertner Nunn Public health officials in Los Angeles County have declared an outbreak of hepatitis A, a highly contagious liver infection driven by a ...

Patients attending Medway Maritime Hospital's A&E will now be routinely tested for HIV and hepatitis unless they opt out. The trust is one of about 50 across the country joining the scheme and ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

The Food and Drug Administration is investigating a new outbreak of hepatitis A infections, but has not yet determined the source of the pathogen. As of the posting of the outbreak announcement ...

Health officials in Los Angeles County have declared an outbreak of hepatitis A. The number of cases tripled from 2023 to 2024, and as NPR's Will Stone reports, there are some concerning trends.

Prince Edward Island has not met its target of eliminating hepatitis C in the province by 2025, but it's still ahead of the rest of Canada in its efforts to reach that goal. In 2015, the ...

In a Phase 2a clinical trial, three patients out of a group treated with nivolumab showed loss of hepatitis B surface antigen (HBsAg) and seroconversion. The study reported a functional cure rate ...